Minims Artificial Tears

Clear, colourless, sterile eye drops containing hyetellose 0.44% w/w BP and sodium chloride EP 0.35% w/w.

Sterile single-use eye drop.

For the relief of dry eye syndromes associated with deficient tear secretion.

One or two drops instilled into the affected eye three or four times daily, or as often as is required.

None known.

If irritation persists or worsens or continued redness occurs, discontinue use and consult a physician or ophthalmologist.

None known.

There is no evidence of safety of the drug in human pregnancy but it has been in wide use for many years without apparent ill consequence. If drug therapy is needed in pregnancy this preparation can be used if recommended by a physician and it is considered that the benefits outweigh the possible risks.

May cause transient blurring of vision on instillation. Do not drive or operate hazardous machinery unless vision is clear.

May cause transient mild stinging or temporarily blurred vision.

Overdose would not be expected to produce symptoms.

The viscolising properties of hyetellose combined with sodium chloride have been shown to increase the tear break-up time in animal models, whilst also acting as a lubricating agent for dry eyes.

Not applicable.

No adverse safety issues were detected during the development of this formulation. The active ingredients are well-established in clinical ophthalmology.

Purified water

Borax

Boric acid

None known.

24 months.

Store below 25°C. Do not freeze. Protect from light.

A sealed conical shaped polypropylene container fitted with a twist and pull off cap. Each Minims unit is overwrapped in an individual polypropylene/paper pouch.

Each Minims unit should be discarded after a single use.

Chauvin Pharmaceuticals Ltd

106 London Road

Kingston-upon-Thames

Surrey

KT2 6TN

United Kingdom

PL 0033/0137

11 January 1990

September 2007